Emd Serono Research & Development Institute, Inc.
Clinical trials sponsored by Emd Serono Research & Development Institute, Inc., explained in plain language.
-
New lupus pill shows promise in reducing skin lesions and disease flares
Disease control CompletedThis study tested whether an oral medication called enpatoran could help control symptoms of lupus, including skin rashes and overall disease activity. 456 people with lupus took either the drug or a placebo pill for 24 weeks while continuing their standard lupus treatments. Rese…
Phase: PHASE2 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for MS patients when old treatments fail
Disease control CompletedThis study looked at how well a drug called cladribine tablets worked for people with relapsing multiple sclerosis (MS) when their previous oral or infusion treatments were not controlling their disease well enough. It followed 291 patients in a real-world setting for two years t…
Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Cancer patients tracked for years after experimental drug trial
Disease control CompletedThis study provided continued access to the cancer drug bintrafusp alfa for 22 patients who had previously benefited from it in earlier trials. Its main goal was to collect long-term safety information and track how long patients lived after treatment. Researchers followed patien…
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Scientists test if new fertility drug pen works like the old vial
Knowledge-focused CompletedThis study tested whether a new, easier-to-use pen version of a fertility hormone drug works the same in the body as the older powder version that needs mixing. Researchers gave 55 healthy men both forms of the drug in a specific order to compare how the body absorbs them. The ma…
Phase: PHASE1 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Knowledge-focused
Last updated Apr 01, 2026 23:26 UTC